首页> 外文期刊>Nanomedicine: Nanotechnology, Biology and Medicine >An antisense oligonucleotide carrier based on amino silica nanoparticles for antisense inhibition of cancer cells
【24h】

An antisense oligonucleotide carrier based on amino silica nanoparticles for antisense inhibition of cancer cells

机译:基于氨基二氧化硅纳米粒子的反义寡核苷酸载体,用于癌细胞的反义抑制

获取原文
获取原文并翻译 | 示例
       

摘要

Antisense oligonucleotides (anti-ODNs),which are able to interfere with gene expression at the mRNA level,have potential activity in the treatment of viral infections or cancer.However,the application of therapies based on anti-ODNs is hampered by their instability to cellular nuclease and their weak intracellular penetration.Among the many efforts to increase their stability and cellular penetration have been modifications of ODNs and introduction of particulate carriers.Here we report an anti-ODNs carrier based on amino silica nanoparticles (NH_2SiNPs) and its preliminary applications in cancer cells.The positively charged NH_2SiNPs were synthesized by a water-in-oil microemulsion method.The NH_2SiNP-ODN complexes were formed by electrostatic interaction, and their cellular uptake was visualized by using fluorescein isothiocyanate (FITC)-labeled ODNs and NH_2SiNPs doped with rhodamine 6G isothiocyanate (RITC) as fluorescent signal indicators. The antisense inhibition efficiency of anti-ODNs delivered by NH_2SiNPs was evaluated using MTT (3,4,5-dimethylthiazol-2,5-diphenyl tetrazolium bromide) assay and western blot analysis.Uniform NH_2SiNPs with an average diameter of 25 nm were obtained and could combine with anti-ODNs to form a bioconjugate favorable for cellular uptake.The NH_2SiNPs were able to protect anti-ODNs from degradation by DNase I.In vitro experiments showed that the NH_2SiNPs could greatly improve the inhibition efficiency of anti-ODNs for the proliferation and survivin expression in Hela cells and A549 cells.Compared with liposomes,the NH_2SiNPs presented a better biocompatibility and had almost no cytotoxicity at the concentrations required for efficient transfection.Our results suggest that the NH_2SiNPs may be a promising carrier for delivery of anti-ODNs.
机译:能够在mRNA水平上干扰基因表达的反义寡核苷酸(anti-ODNs)在治疗病毒感染或癌症方面具有潜在的活性。但是,基于anti-ODNs的治疗方法因其不稳定性而受到阻碍。细胞核酸酶及其弱的细胞内渗透性。在增加其稳定性和细胞渗透性的许多努力中,ODNs的修饰和颗粒载体的引入。在此我们报道了一种基于氨基二氧化硅纳米颗粒(NH_2SiNPs)的抗ODNs载体及其初步应用。通过油包水微乳液法合成带正电荷的NH_2SiNPs,通过静电相互作用形成NH_2SiNP-ODN配合物,并使用异硫氰酸荧光素(FITC)标记的ODN和掺杂的NH_2SiNPs观察其细胞摄取情况。用罗丹明6G异硫氰酸酯(RITC)作为荧光信号指示剂。采用MTT(3,4,5-二甲基噻唑-2,5-二苯基溴化四氮唑)测定和western blot分析评估NH_2SiNPs传递的抗ODNs的反义抑制效率,得到平均直径为25nm的均匀NH_2SiNPs, NH_2SiNPs可以保护DNase I使其免于被DNase I降解。体外实验表明NH_2SiNPs可以大大提高抗ODNs抑制增殖的效率。与脂质体相比,NH_2SiNPs具有更好的生物相容性,并且在有效转染所需的浓度下几乎没有细胞毒性。我们的结果表明,NH_2SiNPs可能是有前景的抗ODNs载体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号